Lates News

AbbVie rose 0.5% in early trading on Wednesday, after the company agreed to offer certain drugs at "most favored nation" prices to medical assistance programs and through the TrumpRx project, and committed to investing $100 billion in research and development in the United States over the next 10 years in exchange for tariff exemptions; Johnson & Johnson reached a similar agreement.